What is Kangji Medical Holdings Operating Cash Flow per Share?
Kangji Medical Holdings's operating cash flow per share for the
six
months ended in Dec. 2024 was HK$0.31.
Kangji Medical Holdings's operating cash flow per share for the trailing twelve months (TTM) ended in Dec. 2024 was HK$0.51.
During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Kangji Medical Holdings was 29.20% per year.
During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 5.50% per year.
During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 10.70% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.
The historical rank and industry rank for Kangji Medical Holdings's Operating Cash Flow per Share or its related term are showing as below:
HKSE:09997'
s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: 0.6 Med: 13.1 Max: 32.5
Current: 5.5
During the past 8 years, Kangji Medical Holdings's highest 3-Year average Operating Cash Flow per Share Growth Rate was 32.50% per year. The lowest was 0.60% per year. And the median was 13.10% per year.
HKSE:09997's 3-Year OCF Growth Rate is ranked worse than 54.89% of 696
companies
in the Medical Devices & Instruments industry
Industry Median: 8.3
vs HKSE:09997: 5.50
Kangji Medical Holdings Operating Cash Flow per Share Historical Data
The historical data trend for Kangji Medical Holdings's Operating Cash Flow per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Kangji Medical Holdings Operating Cash Flow per Share Chart
Competitive Comparison of Kangji Medical Holdings's Operating Cash Flow per Share
For the Medical Instruments & Supplies subindustry, Kangji Medical Holdings's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Kangji Medical Holdings's Price-to-Operating-Cash-Flow Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Kangji Medical Holdings's Price-to-Operating-Cash-Flow distribution charts can be found below:
* The bar in red indicates where Kangji Medical Holdings's Price-to-Operating-Cash-Flow falls into.
Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$0.51
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Kangji Medical Holdings Operating Cash Flow per Share Related Terms
Thank you for viewing the detailed overview of Kangji Medical Holdings's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.
Kangji Medical Holdings Ltd is engaged in the production and sales of minimally invasive surgical instruments and accessories. The principal activities of the company are to design, develop, manufacture and sell a comprehensive suite of MISIA that are focused on the surgical specialties of OBGYN, urology, general surgery and thoracic surgery. The company offers a product portfolio to provide physicians and hospitals with one-shop and tailored surgical solutions for four surgical specialties OBGYN, general surgery, urology, and thoracic surgery. It manufactures and sells both disposable and reusable products. Its product portfolio includes disposable trocars, polymer ligation clips, disposable electrocoagulation forceps, It derives the majority of its revenue from Mainland China.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
HKSE:09997 has been successfully added to your 